Bisphosphonates in the treatment of thalassemia-associated osteoporosis

Thalassemia major is a common cause of skeletal morbidity, as shown by the increased fracture risk in thalassemic patients. The etiology of this bone disease is multifactorial and culminates in a state of increased bone turnover with excessive bone resorption and remodeling. Despite hormonal replace...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of endocrinological investigation 2008-02, Vol.31 (2), p.181-184
Hauptverfasser:	Gaudio, A., Morabito, N., Xourafa, A., Macrì, I., Meo, A., Morgante, S., Trifiletti, A., Lasco, A., Frisina, N.
Format:	Artikel
Sprache:	eng
Schlagworte:	Bone Density Conservation Agents - therapeutic use Diphosphonates - therapeutic use Endocrinology Humans Medicine Medicine & Public Health Metabolic Diseases Osteoporosis - drug therapy Osteoporosis - etiology Short Review Thalassemia - complications Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!